Prednisolone Tablets IP

1. Product Introduction

Prednisolone is a systemic glucocorticoid used under medical supervision to suppress inflammation and modify immune responses. It is prescribed for selected allergic, respiratory, rheumatological, dermatological, hematological and autoimmune disorders. Healthy Life Pharma Pvt. Ltd. is named as manufacturer and Healthy Inc as exporter in the supplied product information; manufacturing and export credentials require document verification.

Prednisolone is not an antibiotic and does not directly cure infections. Because corticosteroids suppress immune responses, infections may worsen or become harder to recognize during treatment.

2. Product Specifications

Available compositions

40 mg and dispersible tablet variants appear in the supplied descriptive copy but not in the confirmed composition list; availability requires verification.

3. Manufacturing Considerations

Low-dose corticosteroid production calls for suitable containment, validated cleaning procedures, consistent blending and robust controls against cross-contamination. Manufacturing processes, granulation method, dedicated equipment and facility certifications must be supported by site-specific records rather than assumed from product category.

4. Quality Assurance

Product quality evaluation should follow the approved IP monograph and applicable regulatory requirements, including identification, assay, uniformity of dosage units, dissolution or disintegration where applicable, impurities and stability. Exact acceptance limits and release criteria must come from the approved specification.

5. Mechanism and Therapeutic Uses

Prednisolone binds intracellular glucocorticoid receptors and alters gene expression to reduce inflammatory mediator activity and immune-cell responses.

• Allergic and inflammatory disorders: Selected severe allergic reactions and inflammatory skin conditions when systemic steroids are appropriate.
• Respiratory disorders: Certain asthma or COPD exacerbations as part of clinician-directed treatment.
• Autoimmune and rheumatological disorders: Conditions such as rheumatoid arthritis, lupus and vasculitis in selected patients.
• Other uses: Selected hematologic and gastrointestinal inflammatory conditions under specialist supervision.

Emergency note: Prednisolone tablets are not a substitute for intramuscular epinephrine (adrenaline) in anaphylaxis.

6. Export and Regulatory Support

For product enquiries, confirm market authorization, product registration status, current manufacturing licenses, applicable GMP certificates, COA, stability information and dossier availability (CTD/ACTD where required). FSC, COPP, packaging configuration, minimum order quantity and shipping terms are subject to document review and commercial agreement.

7. Frequently Asked Questions

What strengths are listed?

Prednisolone Tablets IP 5 mg, 10 mg and 20 mg, each supplied as an uncoated tablet.

Is prednisolone the same as prednisone?

They are closely related corticosteroids; prednisone is converted to prednisolone in the body. They should not be switched without clinical guidance.

Can prednisolone treat an infection?

It does not kill infectious organisms. Steroids may mask signs of infection or increase susceptibility, so a clinician must assess the indication and risks.

Can treatment be stopped suddenly?

After prolonged or sufficiently high-dose treatment, abrupt cessation can cause adrenal insufficiency. Follow the prescriber's tapering plan when required.

8. Dosage and Administration

Dosage and duration depend on the condition, disease severity, response and patient factors. Use only according to the approved product label and prescriber's instructions. Oral prednisolone is often taken with food to reduce gastrointestinal discomfort. Dose reduction may need to be gradual after extended therapy; do not self-adjust or abruptly stop treatment.

9. Side Effects and Precautions

• Common effects: Increased appetite, sleep disturbance, mood changes, indigestion and elevated blood glucose.
• Infection: Immunosuppression can increase infection risk and mask symptoms; active infections require careful assessment.
• Longer-term risks: Osteoporosis, adrenal suppression, hypertension, diabetes, cataracts and glaucoma.
• Important precautions: Review diabetes, peptic ulcer disease, psychiatric history, tuberculosis exposure, vaccination plans and interacting medicines with a clinician.
• Urgent assessment: Seek medical help for severe infection symptoms, black stools, severe mood changes, vision changes or symptoms of adrenal crisis.

Use in pregnancy or children requires individualized clinical risk–benefit assessment.

10. Storage Instructions

Store in the original packaging according to the approved product label, protected from moisture and excessive heat or light as directed. Keep out of reach of children. Confirm the exact storage temperature and expiry period from the marketed pack and stability documentation.